Overview:
Rejuran Skinbooster 3+3 is among the best skincare solutions for good, radiant skin with a healthier look. Because of its high order of skin-boosting capability, widely used among Korean celebrities, this non-invasive procedure is highly improved with advanced technology and superior formulation. Nicknamed the “Hermes” of skin boosters, this Rejuran Skinbooster 3+3 is also combined with Filogra Skin Booster Chanel for ensured quality and performance.
Scientific Validation:
With a large volume of research into its safety and efficacy, more than 2,000 scientific journals have featured Rejuran Skinbooster 3+3, and its testing has been validated at seven major medical centers worldwide. This robust scientific backing ensures its credibility as a trusted and effective skincare solution.
Key Benefits:
- Improves skin elasticity and hydration
- Nourishes the skin deep inside and rejuvenates it
- Skin texture and smoothness improve
- Skin repair and restoration are supported.
- Promotes a radiant, glass-like complexion
Innovative Formulation:
- Rejuran Skinbooster 3+3 is formulated with a powerful blend
- c-PDRN (Polydeoxyribonucleotide): Stimulates skin regeneration and repair
- Hyaluronic Acid (HA): Deeply hydrates and plumps the skin
- Four Types of Amino Acids: Support skin barrier function and elasticity
It reaches an ultra-purified composition by utilizing the patented DOT, or DNA Optimising Technology. The very small molecule size-670 times smaller than the average pore-allows for better skin penetration, hence giving better absorption and delivery of nutrients to the skin areas it targets.
Dual-Action Solution:
Reliably depending on a double solution approach, the Rejuran Skinbooster 3+3 effectively allows the skin health and its externally caused deterioration. Its scientifically developed formulation adds up to visibly healthy and youthful-looking skin, being a must in every person aiming for perfection of complexion.
Box of contend
PDRN+HA 2mL x 3vials
Amino acid 2mL x 3vials
Reviews
There are no reviews yet.